Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
937 GBX | +1.19% | +0.64% | +4.81% |
Mar. 26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
Sales 2022 | -205M -256M | Sales 2023 | -32.42M -40.52M | Capitalization | 303M 379M |
---|---|---|---|---|---|
Net income 2022 | -202M -253M | Net income 2023 | -41M -51.25M | EV / Sales 2022 | -1.96 x |
Net Debt 2022 | 31.74M 39.68M | Net Debt 2023 | 17.4M 21.75M | EV / Sales 2023 | -9.89 x |
P/E ratio 2022 |
-1.84
x | P/E ratio 2023 |
-7.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.66% |
1 day | +1.24% | ||
1 week | +0.06% | ||
Current month | -6.38% | ||
1 month | -4.56% | ||
3 months | +1.92% | ||
6 months | +27.61% | ||
Current year | +4.20% |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Hsu
BRD | Director/Board Member | - | 18-05-15 |
Roger Yates
CHM | Chairman | 67 | 21-11-30 |
Steve Bates
BRD | Director/Board Member | 66 | 15-07-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 937 | +1.19% | 32 238 |
24-04-25 | 926 | -2.53% | 48,374 |
24-04-24 | 950 | -0.21% | 51,910 |
24-04-23 | 952 | +2.92% | 53,195 |
24-04-22 | 925 | -0.64% | 58,909 |
Delayed Quote London S.E., April 26, 2024 at 08:38 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.20% | 387M | |
+2.45% | 14.16B | |
+1.98% | 6.08B | |
+10.79% | 4.29B | |
+12.14% | 4.27B | |
-7.00% | 4B | |
+3.61% | 3.47B | |
+8.60% | 3.2B | |
+6.92% | 2.99B | |
-2.82% | 2.74B |
- Stock Market
- Equities
- BIOG Stock